Major investment accelerates advanced therapies from research to patient
With SEK 36 million in funding, stakeholders in Skåne are joining forces to develop and commercialise breakthrough ATMP research – Advanced Therapy Medical Products. The aim is to accelerate the next generation of these therapies so that more potentially life-saving ATMP treatments reach patients who currently lack effective treatment options Through the ATMP Path2Patient project, stakeholders wil
https://www.innovation.lu.se/en/article/major-investment-accelerates-advanced-therapies-research-patient - 2025-08-23